ROSIPHERSEN

Serial Number 98887179
688

Registration Progress

Application Filed
Dec 5, 2024
Under Examination
Oct 28, 2025
Approved for Publication
Sep 2, 2025
Published for Opposition
Sep 2, 2025
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Apr 28, 2026 100 days

Trademark Image

ROSIPHERSEN

Basic Information

Serial Number
98887179
Filing Date
December 5, 2024
Published for Opposition
September 2, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
688
Status Date
Oct 28, 2025
Application
Pending
Classes
005

Rights Holder

ALPHAROSE THERAPEUTICS INC.

03
Address
1401 LAVACA STREET #851
AUSTIN, TX 78701

Ownership History

Chrysalis Genetics Inc.

Original Applicant
03
Austin, TX

Chrysalis Genetics Inc.

Owner at Publication
03
Austin, TX

ALPHAROSE THERAPEUTICS INC.

New Owner After Publication #1
03
AUSTIN, TX

Legal Representation

Attorney
Kaitlyn M. Garvin

USPTO Deadlines

Next Deadline
100 days remaining
NOA E-Mailed - SOU Required
Due Date
April 28, 2026
Extension Available
Until October 28, 2026

Application History

19 events
Date Code Type Description Documents
Oct 28, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Sep 2, 2025 ASGN I AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Loading...
Sep 2, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 2, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 27, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 1, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 1, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Aug 1, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Aug 1, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Aug 1, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Jul 29, 2025 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jul 29, 2025 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jul 29, 2025 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jun 2, 2025 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jun 2, 2025 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jun 2, 2025 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 26, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
May 17, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 5, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations featuring antisense oligonucleotides for the treatment of genetic diseases and disorders

Classification

International Classes
005